Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$30,000.00

Intracellular trafficking of Fas ligand in cytotoxic T lymphocytes

EF 2013-14

Résumé
There is a type of white blood cell called a T cell that specializes in killing cancer cells or cells that have become infected with viruses or bacteria. This specialized T cell is called a cytotoxic T lymphocyte or CTL. CTL have two very effective ways of killing cells. The first way is the release of a number of proteins from the killer cell, called cytolytic molecules, which are able to enter the defective cell and kill it. The other mechanism is the expression of a molecule on the cell surface called Fas ligand (FasL) that triggers cells that have a molecule called Fas on the cell surface to commit suicide. Since essentially all cells in the body have Fas on the cell surface, the CTL must tightly control the amount of FasL on the cell surface so that they do not go around and trigger all of the cells in the body to commit suicide. We have found that CTL control the amount of FasL on the cell surface by holding the FasL in vesicles, or bags, within the cell. When the CTL recognizes that a cell is abnormal in some way, it then quickly moves the FasL to the cell surface but only in the direction where the normal cell is bound, where it triggers suicide of the cell, and then the FasL rapidly disappears again from the cell surface. This is an effective way to kill only the infected cell while sparing the normal surrounding cells. This study is focused on trying to understand how the FasL is stored in these vesicles in the cell and what triggers it to move to the cell surface. We will use a sophisticated microscope to visualize the movement of FasL in CTL in real time when it encounters an abnormal cell. This will allow us to determine the conditions that cause the movement and deployment of the FasL to the cell surface. We will also gain insight into how cells can control the movement and directional localization of molecules.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
435798-2013
Name nom
Ostergaard, Hanne
Department département
Medical Microbiology and Immunology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5204
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Immunology
Research subject fr
Immunologie
Partie
1
Nb partie
1
Application title
Intracellular trafficking of Fas ligand in cytotoxic T lymphocytes
Keyword
NSERC
Application summary
There is a type of white blood cell called a T cell that specializes in killing cancer cells or cells that have become infected with viruses or bacteria. This specialized T cell is called a cytotoxic T lymphocyte or CTL. CTL have two very effective ways of killing cells. The first way is the release of a number of proteins from the killer cell, called cytolytic molecules, which are able to enter the defective cell and kill it. The other mechanism is the expression of a molecule on the cell surface called Fas ligand (FasL) that triggers cells that have a molecule called Fas on the cell surface to commit suicide. Since essentially all cells in the body have Fas on the cell surface, the CTL must tightly control the amount of FasL on the cell surface so that they do not go around and trigger all of the cells in the body to commit suicide. We have found that CTL control the amount of FasL on the cell surface by holding the FasL in vesicles, or bags, within the cell. When the CTL recognizes that a cell is abnormal in some way, it then quickly moves the FasL to the cell surface but only in the direction where the normal cell is bound, where it triggers suicide of the cell, and then the FasL rapidly disappears again from the cell surface. This is an effective way to kill only the infected cell while sparing the normal surrounding cells. This study is focused on trying to understand how the FasL is stored in these vesicles in the cell and what triggers it to move to the cell surface. We will use a sophisticated microscope to visualize the movement of FasL in CTL in real time when it encounters an abnormal cell. This will allow us to determine the conditions that cause the movement and deployment of the FasL to the cell surface. We will also gain insight into how cells can control the movement and directional localization of molecules.